Cutera, Inc.  

(Public, NASDAQ:CUTR)   Watch this stock  
Find more results for CUTR
-0.37 (-2.75%)
Mar 6 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 12.91 - 13.50
52 week 8.06 - 13.85
Open 13.48
Vol / Avg. 126,518.00/53,022.00
Mkt cap 189.29M
P/E     -
Div/yield     -
EPS -0.75
Shares 14.39M
Beta 1.04
Inst. own 68%
May 6, 2015
Q1 2015 Cutera Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 11, 2015
Cutera Inc at ROTH Conference - 12:30PM EDT - Add to calendar
Feb 5, 2015
Q4 2014 Cutera Inc Earnings Call - Webcast
Feb 5, 2015
Q4 2014 Cutera Inc Earnings Release
Jan 14, 2015
Cutera Inc at Needham Growth Conference
Jan 12, 2015
Cutera Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -6.37% -13.58%
Operating margin -6.24% -13.59%
EBITD margin - -11.88%
Return on average assets -6.04% -9.75%
Return on average equity -8.09% -12.88%
Employees 238 -
CDP Score - -


3240 Bayshore Boulevard
United States - Map
+1-415-6575500 (Phone)
+1-415-3302444 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Cutera, Inc. is a global medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and light-based aesthetics systems for practitioners worldwide. The Company offers products based on six platforms, which include CoolGlide, Xeo, Solera, GenesisPlus, Excel V, and myQ. Each of the Company's laser and light-based platforms consists of one or more hand pieces and a console that incorporates a graphic user interface, a laser or light-based module, control system software and high voltage electronics. In addition to systems and upgrades, the Company generates revenue from the sale of post warranty services, Titan hand piece refills, and Dermal filler and cosmeceuticals. Its CoolGlide, Xeo, Solera, GenesisPlus, Excel V and myQ platforms provide the benefits of laser and light-based aesthetic treatments. On February 2, 2012, it completed its acquisition of certain assets of IRIDEX Corporation´┐Żs (IRIDEX) global aesthetic business.

Officers and directors

Kevin P. Connors President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Ronald J. Santilli Chief Financial Officer, Executive Vice President
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David A. Gollnick Vice President - North American Sales, Director
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David B. Apfelberg M.D. Lead Independent Director
Age: 72
Bio & Compensation  - Reuters
Gregory Barrett Independent Director
Age: 60
Bio & Compensation  - Reuters
Timothy J. O'Shea Independent Director
Age: 61
Bio & Compensation  - Reuters
J. Daniel Plants Independent Director
Bio & Compensation  - Reuters
Clinton H. Severson Independent Director
Age: 66
Bio & Compensation  - Reuters